Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Politics

Bipartisan bill seeks to stop pharmacy middlemen from driving up drug costs for financial gain

by March 19, 2025
March 19, 2025

A bipartisan group of lawmakers is pushing to reform the incentive structure for Pharmacy Benefit Managers (PBMs), arguing that it drives up patient costs by encouraging them to favor higher-priced drugs while withholding potential savings.

Led by physician and GOP Iowa Rep. Mariannette Miller-Meeks, the group introduced the ‘Delinking Revenue from Unfair Gouging (DRUG) Act’ on Tuesday, requiring that PBMs in the commercial market only charge a flat fee for their services related to a specific prescription drug, versus letting them continue to charge a percentage of the drug price. 

PBMs are third-party intermediaries between insurance companies, drug manufacturers and pharmacies that serve to control drug prices and access. The current incentive structure for PBMs, according to the DRUG Act’s sponsors, encourages them to drive up the list price of drugs to increase profits.    

‘Pharmacy benefit managers (PBMs) have excessive influence over the prices patients pay at the pharmacy counter,’ said Miller-Meeks. ‘Local Iowa pharmacies are closing due to greedy PBM practices, impacting proximity and access to medications for Iowans. The DRUG Act will put downward pressure on prescription drug prices and insurance premiums by removing the incentive for PBMs to drive up the list price of medications.’

According to the Iowa Pharmacy Association, PBMs have been using opaque reimbursement models that often pay back pharmacies less than the list cost of a drug and the services provided to dispense it. 

As a result of these practices, pharmacies in Iowa and across the country have been forced to close, the association said in a January report. Twenty-nine Iowa pharmacies and 2,300 pharmacies nationwide closed their doors in 2024, according to the association.  

While PBMs have played important roles in making drugs more widely available, through decades of mergers and acquisitions, the three largest PBMs now manage nearly 80% of all prescriptions filled in the U.S., according to a 2024 report from the Federal Trade Commission. 

The DRUG Act’s reforms serve to address this anti-competitiveness, which the bill’s sponsors say will also help lower costs.

‘Pharmacy Benefit Managers (PBMs) contribute to high drug costs because they are incentivized to steer patients towards drugs that are more profitable for PBMs, but may be less clinically effective for consumers,’ said Rep. Nannette Barragán, D-Calif., one of the bill’s co-sponsors. ‘This broken system disproportionately harms low-income individuals, seniors, and those with chronic illnesses who rely on life-saving prescriptions to manage their health.’

Rep. Donald Norcross, D-N.J., another co-sponsor of the DRUG Act, said families in his district ‘are crying out for relief from high prescription drug prices.’

‘Americans deserve access to quality health care and affordable prescription drugs,’ Norcross said. ‘The DRUG Act reins in prescription drug prices by removing the incentive for pharmacy benefit managers to drive up costs, increasing transparency and prioritizing patients over profits.’

This post appeared first on FOX NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Trump doesn’t use autopen for legally binding documents, unlike Biden, White House says
next post
Vance knocks globalization’s ‘cheap labor’ and lauds ‘America’s great industrial comeback’ at AI summit

You may also like

Daily Recap Weekend Edition: Pelosi, Pelosi, Pelosi…What the...

November 1, 2022

Biden tanked Jimmy Carter’s nominee for CIA over...

January 20, 2023

Democrat-run Minnesota quietly agrees to stop enforcing ‘anti-religious’...

June 16, 2023

House Republicans heap praise on Taiwan’s new leader...

January 26, 2024

WISH LIST: Americans reveal Christmas requests for President...

December 24, 2022

GOP senator roasts John Kerry for jetting off...

December 1, 2023

Joe Biden Channels Mitch McConnell and Brags About...

November 13, 2022

Paul Ryan Trashes Trump: ‘We Stick with Trump,...

November 21, 2022

Hunter Biden-linked account received $5 million days after...

June 24, 2023

Daily Recap Podcast 10-30-22: Katie Hobbs Called Out...

October 31, 2022

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Smaller firms escape Companies House rule change as government pauses ‘burdensome’ filing reform

      July 4, 2025
    • TfL hit with legal action over licence delays impacting Uber and minicab drivers

      July 4, 2025
    • Rachel Reeves hints at fresh tax hikes amid fears of £40bn Budget black hole

      July 4, 2025
    • North Korea lashes out after Trump DOJ exposes massive IT infiltration scheme

      July 4, 2025
    • Wimbledon winners to pay up to £1.3m in tax as HMRC claims £17m from prize pot

      July 4, 2025
    • Saudi defense minister secretly meets with Trump to discuss Iran de-escalation, Israel: sources

      July 4, 2025

    Categories

    • Business (8,383)
    • Investing (2,102)
    • Politics (15,942)
    • Stocks (3,189)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved